Updated
Updated · Bloomberg · Jul 27
Chinese Biotech Overtakes AI as Top EM Growth Trade After 10 Stocks Jump
Updated
Updated · Bloomberg · Jul 27

Chinese Biotech Overtakes AI as Top EM Growth Trade After 10 Stocks Jump

3 articles · Updated · Bloomberg · Jul 27

Summary

  • At least 10 Chinese pharmaceutical stocks have posted double-digit gains, lifting healthcare to the best-performing sector in Bloomberg’s emerging-market benchmark.
  • That rotation has accelerated as the emerging-markets AI rally sputtered, sending Bloomberg’s EM technology index into a bear market over the past month.
  • SK Hynix and Samsung Electronics — emblematic AI winners in emerging markets — slumped 40% and 29%, pushing investors toward Chinese biotech as a new high-growth trade.

Insights

Is Chinese biotech becoming emerging markets’ next growth engine as the AI-chip rally fades?
Can China’s drug innovators turn licensing booms and scientific advances into a lasting stock-market leadership shift?